CTLA4 and cancer: While studies indicate increased expression of inhibitory receptors, such as PD-1 and CTLA-4 on tumor-infiltrating lymphocytes in HCC tissues, as well as their association with patient prognosis [33,34], the challenge of obtaining biopsy samples from all patients with HCC hampers studies on immune cells associated with cancer lesions.